¶ Ciaran Lawlor
This page has moved! Click here to view the most up-to-date version of this page on the White Rose Wiki.
Ciaran Lawlor is an American biotechnology entrepreneur based in Boston, Massachusetts.
¶ Education
Lawlor graduated from Maynooth University, completing a 3 month lab placement at Kings College London. He then received credentials from the Royal College of Surgeons in Ireland (RCSI).[1]
¶ Career
From October 2011 to November 2013, Lawlor worked at PULMATRiX, focusing on “formulation development for pre-clinical studies with small molecules, antibiotics, macromolecules and new chemical entities.”[1:1]
He then went to work at Moderna, where he “helped build internal capabilities on nanoparticle formulation including growing formulation team and acting as lead delivery technology scientist on key strategic partnerships.”
In January 2016, Lawlor was hired at the Boston Consulting Group (BCG), where he was quickly promoted to Principal.
¶ COVID-19
Lawlor co-authored a paper titled “The Near-Term Outlook for COVID-19 Therapeutic Treatments” published by the Boston Consulting Group on May 8, 2020. The paper presented a favourable outlook for the use of the experimental drug remdesivir over a variety of other options to treat COVID-19. Lawlor's co-authors were Jordon Walker, Ahad Wahid and Josh Kellar.[2]
A follow-up article was published on May 14, 2020, titled “The Timelines and Implications for COVID-19 Vaccines”. It was co-authored with Kellar, Wahid, Emily Serazin, Andrew Rodriguez and Philip Berk.[3]
In April 2021, Lawlor left BCG to become Chief Operating Officer of ReNAgade Therapeutics.[1:2][4]
¶ Patents
¶ External links
Ciaran Lawlor. LinkedIn. Retrieved June 14, 2023, from https://www.linkedin.com/in/ciaran-lawlor-919546b/ ↩︎ ↩︎ ↩︎
Lawlor, C., Wahid, A., Walker, J., & Kellar, J. (2020). The Near-Term Outlook for COVID-19 Therapeutic Treatments. Boston Consulting Group. https://web.archive.org/web/20230422204237/https://web-assets.bcg.com/img-src/BCG-The-Near-Term-Outlook-for-COVID-19-Therapeutic-Treatments-May-2020_tcm9-246799.pdf ↩︎
Lawlor, C., Kellar, J., Serazin, E., Rodriguez, A., Berk, P., & Wahid, A. (2020, May 14). The Timelines and Implications for COVID-19 Vaccines. Boston Consulting Group. http://archive.today/2023.06.14-235609/https://www.bcg.com/en-ca/publications/2020/covid-vaccines-timelines-implications ↩︎
Team. ReNAgade Therapeutics. Retrieved June 14, 2023, from https://web.archive.org/web/20230614231455/https://renagadetx.com/team/ ↩︎